JNJ ‘was never dependent on COVID vaccine’ for success: CFO Wolk
Johnson & Johnson (NYSE: JNJ) is trending up this morning after reporting solid results for its third financial quarter. JNJ stock up on improved outlook The stock is being rewarded also because the management raised its guidance for the full year on Tuesday. Johnson & Johnson is now calling for $10.07 to $10.13 of adjusted […]